JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
35 hedge funds and large institutions have $13.6M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
95% less call options, than puts
Call options by funds: $36K | Put options by funds: $690K
Holders
35
Holding in Top 10
–
Calls
$36K
Puts
$690K
Top Buyers
| 1 | +$695K | |
| 2 | +$514K | |
| 3 | +$418K | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$373K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$136K |
Top Sellers
| 1 | -$390K | |
| 2 | -$290K | |
| 3 | -$128K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$43.3K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$13.8K |